Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

Navigating the future(s) of biotech intellectual property

Nature Biotechnology volume 24, pages 249–251 (2006)Cite this article

What changes, if any, can we expect in the system currently used to protect biotech inventions?

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Jensen, K. & Murray, F. Science 310, 239–240 (2005).

    Article  CAS  Google Scholar 

  2. Paradise J., Andrews, L. & Holbrook, T. Science 307, 1566–1567 (2005).

    Article  CAS  Google Scholar 

  3. Heller, M.A. & Eisenberg, R.A. Science 280, 698–701 (1998).

    Article  CAS  Google Scholar 

  4. Walsh, J., Cho, C. & Cohen, W.M. Patents, Material Transfers and Access to Research Inputs in Biomedical Research (Final Report to the National Academy of Sciences' Committee [on] Intellectual Property Rights in Genomic and Protein-Related Research Inventions, 20 September 2005). http://tigger.uic.edu/~jwalsh/WalshChoCohenFinal050922.pdf

    Google Scholar 

  5. Thursby, J. & Thursby, M. Science 301, 1052 (2003).

    Article  CAS  Google Scholar 

  6. Hansen, S., Brewster, A. & Asher, J. Intellectual Property in the AAAS Scientific Community (American Association for the Advancement of Science, Washington, DC, 2005).

    Google Scholar 

  7. Stevens, A.J., Toneguzzo, F. & Bostrom, D. (eds.). AUTM [Association of University Technology Managers] US Licensing Survey, FY 2004: A Survey Summary of Technology Licensing (and Related) Performance for US Academic and Nonprofit Institutions, and Technology Investment Firms. http://www.autm.net/surveys/dsp.surveyDetail.cfm?pid=16

  8. Pressman, L. et al. Nat. Biotechnol. 24, 31–39 (2006).

    Article  CAS  Google Scholar 

  9. National Research Council, Committee on Intellectual Property Rights in Genomic and Protein Research and Innovation. Reaping the Benefits of Genomic and Proteomic Research: Intellectual Property Rights, Innovation, and Public Health (report released 17 November 2005). http://books.nap.edu/catalog/11487.html

  10. Anonymous. Federal Register 64, 72090–72096 (1999).

  11. Anonymous. Federal Register 70, 18413–18415 (2005).

  12. Johnson, E. Nat. Biotechnol. 14, 288–291 (1996).

    Article  CAS  Google Scholar 

  13. Rzucidlo, E. & Auth, D. Nat. Biotechnol. 14, 358–359 (1996).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. covers technology and regulation for The Economist in London,

    Kenneth Neil Cukier

Authors
  1. Kenneth Neil Cukier
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cukier, K. Navigating the future(s) of biotech intellectual property. Nat Biotechnol 24, 249–251 (2006). https://doi.org/10.1038/nbt0306-249

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0306-249

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing